Cvs Pain Relief

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches associated with sore muscles and joints. Specifically, it is effective for conditions such as arthritis, backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended dosage is to spray the product onto the affected areas of the skin up to four times daily. It is not necessary to massage the area after application.

For children under 12 years of age, it is advised to consult a physician prior to use to determine appropriate dosing and administration.

Contraindications

The product is contraindicated in the following situations:

Application is not recommended on wounds or damaged skin, as well as on irritated skin, due to the potential for exacerbating the condition. The use of this product in conjunction with other ointments, creams, sprays, or liniments is contraindicated to prevent adverse interactions. Bandaging the area after application is not advised, as it may alter the product's effectiveness. Additionally, the use of heating pads or devices in conjunction with this product is contraindicated due to the risk of increased absorption and potential adverse effects.

Contact with eyes or mucous membranes should be avoided to prevent irritation. The product should be used only as directed.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from excessive heat or open flames. The contents are under pressure, and it is imperative that the container is not punctured or incinerated. Additionally, storage should not exceed a temperature of 120°F to ensure safety and efficacy.

In the event of accidental ingestion, it is crucial to seek emergency medical assistance immediately or contact a Poison Control Center at 1-800-222-1222.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Monitoring for these signs is essential to ensure patient safety and appropriate management of their condition.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from excessive heat or open flames. The contents are under pressure, and users are advised not to puncture or incinerate the container. Additionally, the product should not be stored at temperatures exceeding 120°F.

In the event that a patient's condition worsens or symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, it is recommended that they stop use and consult a doctor. Furthermore, patients with sensitive skin should seek medical advice before using this product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Pain Relief (menthol 10.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use the product by spraying it onto the affected areas up to four times daily, with no need for massage. For children under 12 years of age, it is advised to consult a physician prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Monitoring of vital signs and laboratory parameters may be warranted to assess the patient's condition and guide further management.

Healthcare professionals should remain vigilant for potential symptoms that could indicate an overdosage scenario, although specific symptoms have not been detailed. If any adverse reactions or unexpected clinical presentations occur, appropriate medical intervention should be sought immediately.

For further guidance, healthcare providers are encouraged to consult local poison control centers or relevant medical authorities to obtain the most current recommendations for managing suspected overdosage cases.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No additional non-teratogenic effects have been identified in the available data. There is no further information provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. Patients should be instructed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using this product, patients must be reminded to follow the directions provided. They should avoid contact with the eyes and mucous membranes, and refrain from applying the product to wounds or damaged skin. It is important to inform patients not to use the product in conjunction with other ointments, creams, sprays, or liniments, and to avoid application on irritated skin. Additionally, patients should not bandage the area after application or use the product with a heating pad or device.

Patients should be counseled to store the product in a cool, dry place away from sunlight and to wash their hands with cool water after use. Furthermore, patients with sensitive skin should be encouraged to consult a doctor before using the product.

Storage and Handling

The product is supplied in a container that is designed to maintain its integrity under specified conditions. It is essential to store the product in a cool, dry place, ensuring it is protected from direct sunlight. The storage temperature must not exceed 120°F to prevent degradation of the product.

Due to its flammable nature, it is crucial to keep the product away from excessive heat sources and open flames. Additionally, the contents are under pressure; therefore, it is imperative not to puncture or incinerate the container to ensure safety and efficacy.

Additional Clinical Information

Patients aged 12 years and older are advised to apply the spray to the affected areas no more than four times daily, without the need for massage. For children under 12 years of age, consultation with a physician is recommended prior to use.

Clinicians should counsel patients to seek medical advice before using the product if they have sensitive skin. During use, patients must adhere to specific precautions: apply only as directed, avoid contact with eyes and mucous membranes, refrain from applying to wounds or damaged skin, and do not use in conjunction with other topical products. Additionally, patients should not apply the spray to irritated skin, bandage the area, or use it with heating devices. It is important to store the product in a cool, dry place away from sunlight and to wash hands with cool water after application. Patients should discontinue use and consult a doctor if their condition worsens or if symptoms persist beyond seven days or recur shortly after resolution. In case of ingestion, immediate medical assistance or contact with a Poison Control Center is necessary. Pregnant or breastfeeding patients should consult a healthcare professional before use.

Drug Information (PDF)

This file contains official product information for Cvs Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)